EP.83Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skippingKathryn R. Wagner, Michael Panzara, Volker Straub et al.|Neuromuscular Disorders|2019Cited by 1